Arcus Biosciences, Inc. (RCUS)

22.72 -0.24 (-1.05%) USD  |  NYSE  |  Apr 06, 14:53
More

Arcus Biosciences SG&A Expense (Semi Annual)

SG&A Expense (Semi Annual) Chart

View SG&A Expense (Semi Annual) for RCUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Semi Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Semi Annual) Range, Past 5 Years

View SG&A Expense (Semi Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Semi Annual) Benchmarks

View SG&A Expense (Semi Annual) Benchmarks
Start Trial
Gilead Sciences, Inc. --
Merck & Co., Inc. --
ACADIA Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. --
Regeneron Pharmaceuticals, Inc. --